Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 431 (RNA5SP431) is classified as a pseudogene of the 5S ribosomal RNA (rRNA) gene family[2][4]. Unlike functional 5S rRNA, which is a highly conserved and essential structural component of the large subunit of ribosomes in all domains of life and required for protein synthesis[1][3], pseudogenes like RNA5SP431 are non-functional genomic DNA sequences that resemble functional genes but are not typically transcribed into functional RNA molecules or translated into proteins. The vast majority of 5S rRNA pseudogenes in the human genome do not encode functional RNA and are considered genomic "fossils" without known physiological or disease relevance[7]. There is no evidence that RNA5SP431 functions as a receptor, enzyme, transporter, drug target, or biomarker. Furthermore, there are no known drugs or therapeutic agents that interact with this pseudogene. Therefore, it is not considered a therapeutic or biological target. Key context: - Pseudogenes are defective copies of genes that no longer produce functional products, typically arising from gene duplication or retrotransposition events[4]. - While some pseudogenes can have regulatory or rare functional roles, the majority—including RNA5SP431—lack any demonstrated role in cell biology or disease, drug interaction, or utility in biomarker assays[7][2]. - The inclusion of "RNA, 5S ribosomal..." designates its family origin (ribosomal RNA), but the addition of "pseudogene" and the individual numeric identifier signifies it is not a functional gene product and not a therapeutic target[2][4]. Summary of why this target is marked as "is_incorrect: true," and "is_target: false": - This molecule is a pseudogene, not a receptor, enzyme, or any functional target relevant to pharmacology or experimental therapeutics[2][4]. - There is insufficient or no evidence for drug, biomarker, or disease involvement, and it should not be considered a target by conventional standards.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 431 (RNA5SP431).